Roesch Lab (@labroesch) 's Twitter Profile
Roesch Lab

@labroesch

The overall focus of our group is the phenotypic tumor heterogeneity in malignant melanoma and the long-term fate of distinct melanoma cell subpopulations.

ID: 1224942224003227649

linkhttps://hautklinik.uk-essen.de/studien-forschung/ag-tumorheterogenitaet-plastizitaet-roesch/ calendar_today05-02-2020 06:26:26

50 Tweet

119 Takipçi

71 Takip Edilen

Roesch Lab (@labroesch) 's Twitter Profile Photo

Amazing talks full of new ideas and concepts at the SMR in Edinburgh Society For Melanoma Research #Melanoma #scientist #canerresearch #Edinburgh. Meeting old friends and collaborators 😎😊

Amazing talks full of new ideas and concepts at the SMR in Edinburgh <a href="/SocietyMelanoma/">Society For Melanoma Research</a> #Melanoma #scientist #canerresearch #Edinburgh. Meeting old friends and collaborators 😎😊
Roesch Lab (@labroesch) 's Twitter Profile Photo

Come check out our Poster #160 (Epigenetic synthetic vulnerabilities and their effects on sequential combination therapy) at the Cromdale Hall at The 19th International Congress of the Society for Melanoma Research. Society For Melanoma Research #melanoma #research

Roesch Lab (@labroesch) 's Twitter Profile Photo

Come check out our Poster at The 19th International Congress of the Society for Melanoma Research. @societymelanoma - via #Whova event app

Come check out our Poster at The 19th International Congress of the Society for Melanoma Research. @societymelanoma - via #Whova event app
Roesch Lab (@labroesch) 's Twitter Profile Photo

Check out or new #liquidbiopsy paper: Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype onlinelibrary.wiley.com/doi/10.1002/ct…

Medizinische Fakultät Essen (@medessen) 's Twitter Profile Photo

Neues aus der #Melanomforschung: Ein Forschungsteam unserer Fakultät Uni Duisburg-Essen @unidue.bsky.social Uniklinikum Essen beschreibt nun in Clinical Cancer Research die Entwicklung von Melanomen, die ihre HLA-II-Moleküle verloren haben uni-due.de/med/meldung.ph… #cancerresearch #krebsforschung #hautkrebs

Neues aus der #Melanomforschung: Ein Forschungsteam unserer Fakultät <a href="/unidue/">Uni Duisburg-Essen @unidue.bsky.social</a> <a href="/UniklinikEssen/">Uniklinikum Essen</a> beschreibt nun in <a href="/CCR_AACR/">Clinical Cancer Research</a> die Entwicklung von Melanomen, die ihre HLA-II-Moleküle verloren haben
uni-due.de/med/meldung.ph…
#cancerresearch #krebsforschung #hautkrebs
Medizinische Fakultät Essen (@medessen) 's Twitter Profile Photo

#Melanomforschung: Ein Team Alexander Roesch Roesch Lab unserer Fakultät Uni Duisburg-Essen @unidue.bsky.social @uniklinikessen und VomLaborInDiePraxis DKFZ zeigt in Nature Cancer, was das Ansprechen auf eine ICI-Therapie beeinflusst. Ziel: Krebstherapien künftig leichter personalisiert auszuwählen udue.de/1466

#Melanomforschung: Ein Team <a href="/RoeschAlexander/">Alexander Roesch</a> <a href="/LabRoesch/">Roesch Lab</a> unserer Fakultät <a href="/unidue/">Uni Duisburg-Essen @unidue.bsky.social</a> @uniklinikessen und <a href="/DKTK_/">VomLaborInDiePraxis</a> <a href="/DKFZ/">DKFZ</a> zeigt in <a href="/NatureCancer/">Nature Cancer</a>, was das Ansprechen auf eine ICI-Therapie beeinflusst. Ziel: Krebstherapien künftig leichter personalisiert auszuwählen
udue.de/1466
Alexander Roesch (@roeschalexander) 's Twitter Profile Photo

Our latest work in Nature Cancer shows how immunotherapy responses of patients with metastatic melanoma are linked to interleukin-17 signaling. 1/ nature.com/articles/s4301…

Roesch Lab (@labroesch) 's Twitter Profile Photo

Among other great talks at the 33. ADO #congress our colleague, Dr. Shannan gave an update on innovative in vitro platforms for #melanoma #research

Among other great talks at the 33. ADO #congress our colleague, Dr. Shannan gave an update on innovative in vitro platforms for #melanoma #research
Roesch Lab (@labroesch) 's Twitter Profile Photo

Excited to be at the 20th #SMR congress in Philadelphia, where Alexander Roesch talked about how IL-17 affects response to dual immune checkpoint inhibition.

Excited to be at the 20th #SMR congress  in Philadelphia, where  <a href="/RoeschAlexander/">Alexander Roesch</a> talked about how IL-17 affects response to dual immune checkpoint inhibition.
José Pedro Friedmann Angeli (@angelifriedmann) 's Twitter Profile Photo

🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉This study has been out for quite some time, but we are delighted to present it in its final form! Huge congratulations to the first authors #FlorencioPF Ancély F dos Santos Hamed Alborzinia @RVZ_Wuerzburg Universität Würzburg #UniWürzburg nature.com/articles/s4158…

Roesch Lab (@labroesch) 's Twitter Profile Photo

OPEN POSITION! Our clinic (Clinic for Dermatology at the University Hospital Essen, Germany) offers an attractive #job opportunity for a senior physician in the field of interventional phlebology. karriere.ume.de/job-finder/?ge… Feel free to share!

Clinical Research Unit CRU 337 (@cru337) 's Twitter Profile Photo

🎉Congratulations to Stefanie Egetemaier from our #cru337 @labRoesch for successfully defending her PhD thesis on June 26, 2024! 🎓 We're very proud of her achievement and excited to see the impact of her work within our research community. Well done! 👏 #WomenInScience #unidue

🎉Congratulations to Stefanie Egetemaier from our #cru337 @labRoesch for successfully defending her PhD thesis on June 26, 2024! 🎓 We're very proud of her achievement and excited to see the impact of her work within our research community. Well done! 👏 #WomenInScience #unidue